HYPHA LABS (FUNI) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 27, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FUNI SEC filings page.
This page shows HYPHA LABS, INC. (FUNI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
By FY2025, the balance sheet had shrunk while liabilities dominated assets and cash generation remained negative.
FY2025 operating cash flow was-$380K and free cash flow was-$413K , so the cash shortfall was primarily operating rather than a consequence of heavy reinvestment. That distinction matters because it points to the business consuming cash through its ongoing activities, not mainly through expansionary capital spending.
Liabilities equaled
Selling, general and administrative expense reached
Financial Health Signals
HYPHA LABS, INC. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
HYPHA LABS, INC.'s EBITDA was -$86K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
HYPHA LABS, INC. reported a net loss of $305K in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
HYPHA LABS, INC. earned $0.00 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2026.
Cash & Balance Sheet
HYPHA LABS, INC. held $5K in cash against $1.8M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
None of these metrics is reported for Q3 2026.
Capital Allocation
None of these metrics is reported for Q3 2026.
FUNI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| SG&A Expenses | $66K-18.7% | $114K+19.8% | $186K-82.4% | N/A | $82K-83.2% | $95K-47.7% | $1.1M+7056.7% | N/A |
| Operating Income | -$96Kn/m | -$420Kn/m | -$475K | N/A | -$536Kn/m | -$669Kn/m | N/A | N/A |
| EBITDA | -$86Kn/m | -$407Kn/m | -$463K | N/A | -$522K | -$658K | N/A | N/A |
| Interest Expense | $155K+494.4% | $101K+344.5% | $47K+108.4% | N/A | $26K+20.2% | $23K-69.4% | $22K-73.5% | N/A |
| Net Income | -$305Kn/m | -$521Kn/m | -$522K | N/A | -$562Kn/m | -$642K-372.2% | N/A | N/A |
| EPS (Basic) | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | -$0.01n/m | -$0.01n/m |
| EPS (Diluted) | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | -$0.01n/m | -$0.01n/m |
| Diluted Shares (Avg) | 164M+19.7% | 159M+21.6% | 152M+21.7% | N/A | 137M+27.1% | 131M+42.4% | 125M+43.1% | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, Income Tax.
FUNI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $68K-85.0% | $160K-37.8% | $392K+51.4% | $409K-17.1% | $454K-39.6% | $257K-81.5% | $259K-83.0% | $494K-65.0% |
| Current Assets | $15K-95.5% | $96K-48.5% | $315K+77.0% | $321K-21.9% | $340K-53.7% | $187K-86.5% | $178K-79.6% | $410K-46.4% |
| Cash & Equivalents | $5K-96.5% | $82K+289.7% | $43K+17.1% | $38K-58.2% | $147K-71.1% | $21K-98.0% | $37K-88.1% | $91K-66.4% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $3.5M+38.4% | $3.3M+57.9% | $3.1M+68.8% | $2.8M+62.2% | $2.5M+44.6% | $2.1M+11.7% | $1.8M-49.0% | $1.8M-51.5% |
| Current Liabilities | $1.6M-27.2% | $1.4M-17.2% | $1.3M-10.3% | $1.1M-19.7% | $2.2M+55.2% | $1.7M+13.8% | $1.5M-52.3% | $1.4M-55.4% |
| Non-Current Liabilities | $1.9M+468.5% | $1.8M+26811.5% | $1.8M+10266.1% | $1.7M+6335.0% | $334K0.0% | $7K-97.9% | $17K-88.7% | $27K-83.1% |
| Long-Term Debt | $1.8M | $1.8M | $1.3M | $1.3M | N/A | N/A | N/A | N/A |
| Total Equity | -$3.4Mn/m | -$3.1Mn/m | -$2.7Mn/m | -$2.4Mn/m | -$2.1Mn/m | -$1.8Mn/m | -$1.6Mn/m | -$1.3Mn/m |
| Retained Earnings | -$25.0Mn/m | -$24.7Mn/m | -$24.2Mn/m | -$23.6Mn/m | -$23.1Mn/m | -$22.5Mn/m | -$21.9Mn/m | -$20.5Mn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.
FUNI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$52Kn/m | -$51Kn/m | -$150Kn/m | -$315Kn/m | -$23Kn/m | -$34Kn/m | -$8K-112.3% | -$436K-784.5% |
| Depreciation & Amortization | $10K-23.6% | $14K+24.1% | $12K+165.0% | $13K+1310.6% | $14K | $11K | $4K | $900 |
| Stock-Based Compensation | N/A | N/A | $218K-78.9% | N/A | N/A | N/A | $1.0M+89696.7% | N/A |
| Capital Expenditures | N/A | N/A | N/A | $31K+206.6% | $0 | -$1 | $2K | $10K |
| Free Cash Flow | N/A | N/A | N/A | -$346Kn/m | -$23K | -$34K | -$10K | -$446K |
| Investing Cash Flow | N/A | N/A | N/A | -$31K-165.1% | $0n/m | $1-100.0% | -$2Kn/m | $48Kn/m |
| Financing Cash Flow | -$25K-116.7% | $90K+395.4% | $155Kn/m | $237Kn/m | $149Kn/m | $18Kn/m | -$45Kn/m | -$30Kn/m |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
FUNI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$2.4M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.29), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| HYPHA LABS, INC. FUNI | FY2025 | N/A | N/A | N/A | $606K | — |
| INTERPACE BIOSCIENCES NEW IDXG | FY2025 | $38.7M | $24.6M | 63.5% | $32.5M | — |
Where HYPHA LABS, INC. Ranks
Frequently Asked Questions
How much debt does HYPHA LABS, INC. have?
As of fiscal year 2025, HYPHA LABS, INC. (FUNI) had $38K in cash and equivalents against $1.3M in long-term debt.
What is HYPHA LABS, INC.'s free cash flow?
HYPHA LABS, INC. (FUNI) recorded an outflow of $413K in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is HYPHA LABS, INC.'s operating cash flow?
HYPHA LABS, INC. (FUNI) recorded an outflow of $380K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are HYPHA LABS, INC.'s total assets?
HYPHA LABS, INC. (FUNI) had $409K in total assets as of fiscal year 2025, including both current and long-term assets.
What are HYPHA LABS, INC.'s capital expenditures?
HYPHA LABS, INC. (FUNI) invested $33K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is HYPHA LABS, INC.'s current ratio?
HYPHA LABS, INC. (FUNI) had a current ratio of 0.29 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is HYPHA LABS, INC.'s P/E ratio?
HYPHA LABS, INC. (FUNI) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $606K as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is HYPHA LABS, INC.'s price-to-sales ratio?
HYPHA LABS, INC. (FUNI) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $606K as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does HYPHA LABS, INC.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, HYPHA LABS, INC. (FUNI) held $38K in cash, cash equivalents and investments, and reported an operating cash outflow of $380K over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is HYPHA LABS, INC.'s debt-to-equity ratio negative or not reported?
HYPHA LABS, INC. (FUNI) has negative shareholder equity of -$2.4M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.